Tampa, FL – Healthesystems recently announced the publishing of the newest edition of its twice-annual industry journal, RxInformer.
The winter 2023/2024 edition explores evolving areas of interest across workers’ comp healthcare, from artificial intelligence to mental health and psychedelics.
Articles include:
The Real Promise of Artificial Intelligence in Healthcare and Workers’ Comp
AI capabilities are advancing rapidly, with new applications becoming available for healthcare and workers’ comp. Learn about the potential applications, benefits, pitfalls, questions, and the matter of regulation.
The Mind-Body Connection: Exploring the Relationship Between Injury and Mental Health
Physical injuries are often accompanied by mental health disorders such as depression, increasing workers’ comp claim costs and delaying recovery.
Changing Minds? Unlocking the Potential of Psychedelics in Mental Health Therapy
Explore the growing interest in research around psychedelic substances for medical applications related to workers’ comp populations, including psilocybin, ketamine, MDMA, and more.
Beyond Opioids: Drugs of Concern in Workers’ Compensation
As opioid utilization decreases, other pharmacy trends bear watching. This infographic presents recent drugs of concern in workers’ comp.
Ask a Clinician: What Do I Need to Know About DME Trends?
Healthesystems clinicians tackle questions about Durable Medical Equipment trends.
Key regulation impacting the workers’ comp industry
AVP of Advocacy and Compliance Sandy Shtab provides commentary on regulatory activity around the country.
Access the issue online here: https://healthesystems.com/rxinformer/.
Source: Healthesystems
Disclosure:
Healthesystems is a WorkCompWire ad partner.
This is NOT a paid placement.